You are here: Industry Insights > COVID-19

News List

Regeneron Announces Initial Data from COVID-19 Antibody Cocktail Trial americanpharmaceuticalreview
December 31, 2020
Regeneron Pharmaceuticals has announced encouraging initial data from an ongoing Phase 1/2/3 clinical trial of the Regeneron antibody cocktail, casirivimab and imdevimab, in hospitalized COVID-19 patients requiring low-flow oxygen.
HMD completes order of 140 mn KOJAK AD Syringes for global COVID-19 vaccination campaigns expresspharma
December 31, 2020
The company has shipped the last batch of 35 million pieces of KOJAK Auto Disable Syringes to Covax stockpile facility via UNICEF.
Sustained cellular immune dysregulation in individuals recovering from COVID-19 worldpharmanews
December 30, 2020
COVID-19, which has killed 1.7 million people worldwide, does not follow a uniform path.Many infected patients remain asymptomatic or have mild symptoms.
INEX Innovate's CORO(TM) Real-Time RT-PCR SARS-CoV-2 Kit for the detection of COVID-19 obtains Singapore's Health Sciences Authority Provisional Authorisation prnasia
December 30, 2020
INEX Innovate Pte Ltd a Singapore based molecular diagnostics developer announced that the Singapore Health Sciences Authority has issued provisional authorisation to the company's CORO? Real-Time RT-PCR SARS-CoV-2 for the diagnosis of COVID-19.
Vaccines in pipeline will work against the new COVID-19 variants: Dr K Raghavan expresspharma
December 30, 2020
Committee of experts to soon give report on the process of identifying and prioritising patients with co-morbidities, for the purpose of vaccination: Dr VK Paul.
Universiti Teknologi Malaysia Community responded to COVID-19 threats through R&D prnasia
December 29, 2020
Researchers from Universiti Teknologi Malaysia (UTM) have swung into action to respond to the threat posed by COVID-19 pandemic.
Soligenix Announces $1.5 Million NIH Small Business Innovation Research Award Advancing COVID-19 Vaccine Development prnewswire
December 29, 2020
Soligenix, Inc., a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced that the National Institute of Allergy and Infectious Diseases (NIAID) ...
Merck announces supply agreement with US for initial doses of investigational biological therapy to treat Covid-19 pharmaceutical-business-review
December 29, 2020
Merck acquired MK-7110 through the acquisition of OncoImmune, a privately held, clinical-stage biopharmaceutical company.
Can IPRs be part of the COVID-19 solution, rather than the problem? expresspharma
December 29, 2020
As the USTR’s Special 301 Review for 2021 starts, calls for the WTO to declare an IPR waiver on all COVID-19 related medical products will pick up pace. It’s time to find middle ground.
SEC asks Bharat Serums to revise phase I/II trial protocols for equine antiserum to treat COVID-19 expresspharma
December 29, 2020
The SEC has recommended grant of permission to conduct the clinical trial provided the company submits the revised clinical trial protocol to CDSCO.